Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on July 13, 2023, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an aggregate of 66,066 shares of its common stock to seven new employees, consisting of stock options to purchase an aggregate of 30,033 shares of common stock and restricted stock units ("RSUs"), covering an aggregate of 30,033 shares of its common stock.

These stock options and inducement RSUs are subject to the terms of the Seres Therapeutics, Inc. 2022 Employment Inducement Award Plan (the "Inducement Plan").

The Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to their entering into employment with Seres pursuant to Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was adopted by Seres' board of directors in December 2022.

The stock options have an exercise price of $4.61 per share. Each option will vest as to 25% of the total number of shares subject to the option on the first anniversary of the applicable individual's date of hire and as to 6.25% of the total number of shares subject to the option upon a completion of each three full months of service to the Company thereafter. The RSUs vest as to 25% of an award on the first 15th day of a calendar month that immediately follows the first anniversary of the applicable individual's date of hire and as to an additional 6.25% of the award, upon completion of each three full months of service to the Company thereafter.

About Seres Therapeutics

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. For more information, please visit www.serestherapeutics.com.


These press releases may also interest you

at 11:00
The Physician-Patient Alliance for Health & Safety (PPAHS) is pleased to announce that Graceland Rehabilitation and Nursing Center in Memphis, TN, is the first nursing facility in West Tennessee to...

at 11:00
Thinx, the #1 selling reusable period underwear brand in retail, has launched styles featuring its new LeakSafetm Barrier technology. Available across all products ? Thinx, Thinx Teens®, and Thinx for Alltm ? the innovation offers all-day absorbency...

at 11:00
AIxMed, innovators and providers of an AI-powered computational platform for cytology applications, and CorePlus a leader in precision pathology have entered into an agreement to conduct a pilot study applying the AIxMed's AI algorithm to test a...

at 10:50
Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with published results, today launched Kohere.ai, its proprietary cloud-based platform that augments the company's proven model of care (MoC) for cardiovascular...

at 10:49
The Multiple Sclerosis Association of America (MSAA) is excited to invite members of the MS community to our 10th Improving Lives Benefit on Wednesday, May 15, 2024, at 6:30 pm ET, at the Barnes Foundation in Philadelphia, PA. This event will also be...

at 10:48
Glytec, whose industry leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to the home, announces a major step forward in its advocacy and partnership efforts to drive excellence in diabetes care and...



News published on and distributed by: